Laszlo Tibor Nagy
Impact in
- Immunology top 0.5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Molecular Biology top 0.5%
- Peroxisome Proliferator-Activated Receptors
- Retinoids in leukemia and cellular processes
Papers in
- Immunology 64
- Immune cells in cancer 27
- Immune Cell Function and Interaction 25
-
- Peroxisome Proliferator-Activated Receptors 41
- Retinoids in leukemia and cellular processes 36
- Epigenetics and DNA Methylation 16
- Co-authors
- Ronald Evans (10 shared papers)Peter Tontonoz (8 shared papers)Jacqueline G. A. Alvarez (2 shared papers)Richard Jirui Lin (3 shared papers)Vilmos A. Thomázy (9 shared papers)Zsolt Czimmerer (20 shared papers)Attila Szántó (18 shared papers)Tamás Varga (13 shared papers)
- Journals
- Journal of Biological Chemistry (8 papers)The Journal of Immunology (8 papers)Immunity (7 papers)Molecular and Cellular Biology (6 papers)Cell Death and Differentiation (6 papers)
- Partner nations
- HungaryUnited StatesGermany
In The Last Decade
Laszlo Tibor Nagy
280 papers receiving 20.0k citations
Laszlo Tibor Nagy's Hit Papers
Peers
Comparison fields: 5 of 175
- Immunology 4.0k
- Molecular Biology 12.1k
- Biochemistry 1.1k
- Cancer Research 1.9k
- Biochemistry 725
Countries citing papers authored by Laszlo Tibor Nagy
This map shows the geographic impact of Laszlo Tibor Nagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laszlo Tibor Nagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laszlo Tibor Nagy more than expected).
Fields of papers citing papers by Laszlo Tibor Nagy
This network shows the impact of papers produced by Laszlo Tibor Nagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laszlo Tibor Nagy. The network helps show where Laszlo Tibor Nagy may publish in the future.
Co-authors
The 25 scholars most cited alongside Laszlo Tibor Nagy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 295 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ Hit paper breakdown → | 1998 | 1629 |
| 2 | PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL Hit paper breakdown → | 1998 | 1595 |
| 3 | Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 Hit paper breakdown → | 1997 | 1285 |
| 4 | A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis Hit paper breakdown → | 2001 | 1215 |
| 5 | Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase Hit paper breakdown → | 1997 | 1083 |
| 6 | PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Hit paper breakdown → | 2001 | 979 |
| 7 | Role of the histone deacetylase complex in acute promyelocytic leukaemia Hit paper breakdown → | 1998 | 956 |
| 8 | PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation Hit paper breakdown → | 2011 | 796 |
| 9 | 2008 | 399 | |
| 10 | 2010 | 387 | |
| 11 | 2004 | 335 | |
| 12 | 2000 | 261 | |
| 13 | 2004 | 248 | |
| 14 | Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Hit paper breakdown → | 2022 | 245 |
| 15 | 1995 | 229 | |
| 16 | 2018 | 202 | |
| 17 | 2009 | 199 | |
| 18 | 2018 | 197 | |
| 19 | 2012 | 182 | |
| 20 | 2006 | 170 |
About Laszlo Tibor Nagy
Laszlo Tibor Nagy is a scholar working on Immunology, Molecular Biology, Surgery, Gastroenterology and Genetics, having authored 295 papers that have together received 20.6k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (41 papers), Retinoids in leukemia and cellular processes (36 papers), Helicobacter pylori-related gastroenterology studies (30 papers), Immune cells in cancer (27 papers), Immune Cell Function and Interaction (25 papers), Estrogen and related hormone effects (17 papers), Epigenetics and DNA Methylation (16 papers) and Cholesterol and Lipid Metabolism (14 papers). The work is most often cited by research in Immunology (4.0k citations), Molecular Biology (12.1k citations), Biochemistry (1.1k citations), Cancer Research (1.9k citations) and Biochemistry (725 citations). Laszlo Tibor Nagy has collaborated with scholars based in Hungary, United States and Germany. Frequent co-authors include Ronald Evans, Peter Tontonoz, Jacqueline G. A. Alvarez, Richard Jirui Lin, Vilmos A. Thomázy, Zsolt Czimmerer, Attila Szántó, Tamás Varga, Hong-Wu Chen and Yaacov Barak. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology, Immunity, Molecular and Cellular Biology and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.